Nikhil C. Munshi

Specialty: Multiple Myeloma Genomics

Location: Unknown

Tier: ELITE

H-Index: 107

Years Active: 0

Hospital Affiliations

• Harvard University - Faculty

Key Publications

1. "International Myeloma Society/International Myeloma Working Group Consensus Recommendations on the Definition of High-Risk Multiple Myeloma." - J Clin Oncol (2025)
2. "Signatures of mutational processes in human cancer." - Nature (2013)
3. "Ciltacabtagene autoleucel, a B-cell maturation antigen-directed chimeric antigen receptor T-cell therapy in patients with relapsed or refractory multiple myeloma (CARTITUDE-1): a phase 1b/2 open-label study." - Lancet (2021)
4. "Idecabtagene Vicleucel in Relapsed and Refractory Multiple Myeloma." - N Engl J Med (2021)
5. "Consensus guidelines and recommendations for infection prevention in multiple myeloma: a report from the International Myeloma Working Group." - Lancet Haematol (2022)

Knowledge Graph Relationships

Nikhil C. Munshi is a Multiple Myeloma Genomics specialist affiliated with Harvard University. Authored 5 scholarly articles.